Want to join the conversation?
$OREX 2Q15 Call: In 1H15, overall market was up 14% vs. 1H14. Now, overall market grew about 10% for 2014 vs. 2013. Branded market, including Xenical, Qsymia, Belviq, Contrave and Saxenda, was up about 101% for 1H15 vs. 1H14. In the long term, market has very strong potential given the low treatment penetration rates in huge unmet needs.
Vine, the unique app from $TWTR is no more! Perfect example for mass products that don't make money!
$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?
Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?
Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein